# pleural mesothelioma stages

Study Evaluating Efficacy and Safety of Capmatinib in Combination With Osimertinib in Adult Subjects With Non-small Cell Lung Cancers as Second Line Therapy » Study Evaluating Efficacy and Safety of Capmatinib in Combination With Osimertinib in Adult Subjects With Non-small Cell Lung Cancers as Second Line Therapy - NCT04816214 Cancer.gov

Palbociclib, Letrozole, and Trastuzumab before Surgery in Treating Patients with Estrogen Receptor Positive and HER2 Positive Stage II-III Breast Cancer » Palbociclib, Letrozole, and Trastuzumab before Surgery in Treating Patients with Estrogen Receptor Positive and HER2 Positive Stage II-III Breast Cancer - NCT02907918 Cancer.gov

An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide » An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide - NCT02400476 Cancer.gov

Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors » Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors - NCT04608045 Cancer.gov

Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1 » Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1 - NCT04795713 Cancer.gov

Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma » Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma - NCT02899195 Cancer.gov

A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer » A Study Investigating DNA-damage Response Agents in Molecularly Altered Advanced Cancer - NCT04564027 Cancer.gov

A Study to Evaluate the Effects of Pevonedistat on the Corrected QT (QTc) Interval in Participants With Advanced Solid Tumors » A Study to Evaluate the Effects of Pevonedistat on the Corrected QT (QTc) Interval in Participants With Advanced Solid Tumors - NCT03330106 Cancer.gov

Erlotinib Hydrochloride before Surgery in Treating Patients with Stage III Non-Small Cell Lung Cancer » Erlotinib Hydrochloride before Surgery in Treating Patients with Stage III Non-Small Cell Lung Cancer - NCT01857271 Cancer.gov